We are live on ! Find out more
Two Sigma Advisers

Two Sigma Advisers Portfolio holdings

AUM $51.4B
1-Year Est. Return 31.07%
This Fund
S&P 500
This Quarter Est. Return
-2.68%
1 Year Est. Return
+31.07%
3 Year Est. Return
+128.94%
5 Year Est. Return
+161.75%
10 Year Est. Return
+607.04%
AUM
$39B
AUM Growth
-$220M
Cap. Flow
+$1.59B
Cap. Flow %
4.06%
Top 10 Hldgs %
16.38%
Holding
2,663
New
306
Increased
844
Reduced
1,189
Closed
301

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$592M
2
TSLA icon
Tesla
TSLA
+$492M
3
AMZN icon
Amazon
AMZN
+$474M
4
AMD icon
Advanced Micro Devices
AMD
+$410M
5
QCOM icon
Qualcomm
QCOM
+$358M

Top Sells

Rank Stock Value
1
SCHW
Charles Schwab
SCHW
+$393M
2
UNP icon
Union Pacific
UNP
+$363M
3
WMT icon
Walmart Inc
WMT
+$239M
4
C icon
Citigroup
C
+$192M
5
COP icon
ConocoPhillips
COP
+$172M

Sector Composition

Rank Sector Weight
1 Technology 24.84%
2 Healthcare 15.27%
3 Consumer Discretionary 13.96%
4 Industrials 10.47%
5 Financials 8.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CRGE
2351
DELISTED
Charge Enterprises, Inc. Common Stock
CRGE
$7.61K ﹤0.01%
15,300
-500
-3% -$376
PVLA
2352
Palvella Therapeutics
PVLA
$2.05B
$7.27K ﹤0.01%
305
+42
+16% +$903
MRIN
2353
DELISTED
Marin Software
MRIN
$5.4K ﹤0.01%
2,117
+150
+8% +$517
INO icon
2354
Inovio Pharmaceuticals
INO
$84.7M
$5.13K ﹤0.01%
1,100
-38,633
-97% -$213K
ONCO icon
2355
Onconetix
ONCO
$3.06M
0
BZFD icon
2356
BuzzFeed
BZFD
$104M
$4.97K ﹤0.01%
3,250
-75
-2% -$147
BODI icon
2357
The Beachbody Company
BODI
$78.4M
$4.72K ﹤0.01%
320
-6
-2% -$120
DCFC
2358
DELISTED
Tritium DCFC Limited Ordinary Shares
DCFC
$4.33K ﹤0.01%
72
-45
-38% -$8.56K
KRRO icon
2359
Korro Bio
KRRO
$151M
$3.77K ﹤0.01%
+204
New +$5.12K
NTBL
2360
DELISTED
Notable Labs, Ltd. Ordinary Shares
NTBL
$3.67K ﹤0.01%
+429
New +$3.75K
PZG icon
2361
Paramount Gold Nevada
PZG
$93.5M
$3.58K ﹤0.01%
12,600
ASXC
2362
DELISTED
Asensus Surgical, Inc.
ASXC
$3.35K ﹤0.01%
12,400
-100
-0.8% -$36
AAOI icon
2363
Applied Optoelectronics
AAOI
$7.07B
-69,000
Closed -$411K
ABUS icon
2364
Arbutus Biopharma
ABUS
$871M
-13,700
Closed -$31.5K
ACGL icon
2365
Arch Capital
ACGL
$37.2B
-17,400
Closed -$1.3M
ACHC icon
2366
Acadia Healthcare
ACHC
$3.01B
-7,600
Closed -$605K
ACMR icon
2367
ACM Research
ACMR
$4.98B
-74,500
Closed -$974K
ACR
2368
ACRES Commercial Realty
ACR
$129M
-12,067
Closed -$107K
ADM icon
2369
Archer Daniels Midland
ADM
$40.1B
-96,900
Closed -$7.32M
ADPT icon
2370
Adaptive Biotechnologies
ADPT
$3.6B
-14,800
Closed -$99.3K
AER icon
2371
AerCap
AER
$24.3B
-9,500
Closed -$603K
ALC icon
2372
Alcon
ALC
$33.7B
-5,130
Closed -$421K
ALHC icon
2373
Alignment Healthcare
ALHC
$3.81B
-18,300
Closed -$105K
ALGS icon
2374
Aligos Therapeutics
ALGS
$26.3M
-2,096
Closed -$50.9K
ALL icon
2375
Allstate
ALL
$70.1B
-1,900
Closed -$207K

Similar funds

Two Sigma Advisers's Q3 2023 Portfolio in Review

As of Q3 2023, Two Sigma Advisers held 2,663 positions worth $39B, down 0.56% from $39.3B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Two Sigma Advisers deployed $1.59B of net new capital in Q3 2023, opening 306 new positions and adding to 844 existing holdings. Its largest new stake was Advanced Micro Devices: 3,777,240 shares worth $388M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Charles Schwab, an estimated $393M trimmed.

  • Two Sigma Advisers's largest Q3 2023 buy was Advanced Micro Devices: 3,777,240 shares worth $388M.
  • Two Sigma Advisers added most to Microsoft in Q3 2023, an estimated $592M increase.
  • Two Sigma Advisers's biggest Q3 2023 reduction was Charles Schwab, cutting an estimated $393M.
  • Two Sigma Advisers fully exited Uber in Q3 2023, selling an estimated $109M.
  • Two Sigma Advisers's ten largest holdings make up 16% of its $39B portfolio in Q3 2023.
  • Two Sigma Advisers opened 306 new positions and closed 301 in Q3 2023.
  • Two Sigma Advisers's portfolio value fell 0.56% quarter-over-quarter to $39B.

Based on Two Sigma Advisers's 13F filing for Q3 2023, filed 14 Nov 2023.